People
Tim FitzSimons is a partner in King & Spalding’s Corporate, Finance and Investments practice. He has advised companies on public and private M&A transactions totaling more than US$200 billion. He represents directors in conflict of interest transactions and corporate governance and shareholder activism/takeover defense matters. He also has represented private equity and venture capital investors and portfolio companies and financial advisors in M&A transactions.
Tim speaks and writes on M&A topics, including developments in public company M&A matters, activist hedge funds, and corporate governance.
J.D., Northwestern Pritzker School of Law
B.A., University of Notre Dame
Illinois
New York
October 15, 2024
Beyond, Inc. Invests in The Container Store
September 24, 2024
Tim FitzSimons examines the likelihood of an uptick in M&A activity in response to the Federal Reserve’s recent rate cut
September 23, 2024
King & Spalding Earns Multiple Practice and Individual Rankings in 2024 IFLR1000 Guide
Advised United Parcel Service, Inc. (NYSE: UPS) in the $800 million sale of its UPS Ground Freight, Inc. to TFI International Inc. (NYSE and TSX: TFII)
Advised the Special Committee of the Board of Directors of Genentech in its $46.8 billion merger with Roche Holdings
Advised CBOT Holdings in its $12 billion merger with Chicago Mercantile Exchange Holdings (including the intervening unsolicited offer from InterContinental Exchange)
See more
October 18, 2023
Reconsider That Term Sheet: DOJ "Safe Harbor Policy" Announcement Incentivizes Merger-Related Disclosures
October 15, 2024
Beyond, Inc. Invests in The Container Store
September 24, 2024
Tim FitzSimons examines the likelihood of an uptick in M&A activity in response to the Federal Reserve’s recent rate cut
September 23, 2024
King & Spalding Earns Multiple Practice and Individual Rankings in 2024 IFLR1000 Guide
Advised United Parcel Service, Inc. (NYSE: UPS) in the $800 million sale of its UPS Ground Freight, Inc. to TFI International Inc. (NYSE and TSX: TFII)
Advised the Special Committee of the Board of Directors of Genentech in its $46.8 billion merger with Roche Holdings
Advised CBOT Holdings in its $12 billion merger with Chicago Mercantile Exchange Holdings (including the intervening unsolicited offer from InterContinental Exchange)
See more
October 18, 2023
Reconsider That Term Sheet: DOJ "Safe Harbor Policy" Announcement Incentivizes Merger-Related Disclosures
October 15, 2024
Beyond, Inc. Invests in The Container Store
September 24, 2024
Tim FitzSimons examines the likelihood of an uptick in M&A activity in response to the Federal Reserve’s recent rate cut
September 23, 2024
King & Spalding Earns Multiple Practice and Individual Rankings in 2024 IFLR1000 Guide
J.D., Northwestern Pritzker School of Law
B.A., University of Notre Dame
Illinois
New York